Page last updated: 2024-09-02

ecopipam and triazolam

ecopipam has been researched along with triazolam in 1 studies

Compound Research Comparison

Studies (ecopipam)	Trials (ecopipam)	Recent Studies (post-2010) (ecopipam)	Studies (triazolam)	Trials (triazolam)	Recent Studies (post-2010) (triazolam)
147	18	34	1,275	385	90

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chausmer, AL; Griffiths, RR; Kelly, RY; Smith, BJ	1

Trials

1 trial(s) available for ecopipam and triazolam

Article	Year
Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166). Behavioural pharmacology, 2003, Volume: 14, Issue:2 Topics: Adult; Benzazepines; Blood Pressure; Cocaine-Related Disorders; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; GABA Modulators; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Pain Measurement; Receptors, Dopamine D1; Time Factors; Triazolam	2003

Article

Year

Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).

Behavioural pharmacology, 2003, Volume: 14, Issue:2

Topics: Adult; Benzazepines; Blood Pressure; Cocaine-Related Disorders; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; GABA Modulators; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Pain Measurement; Receptors, Dopamine D1; Time Factors; Triazolam

2003